Evidence map›Paper›PMID 28495679›Full record

ArticleThe EMBO journal2017

Autophagosome formation is initiated at phosphatidylinositol synthase-enriched ER subdomains.

Taki Nishimura, Norito Tamura, Nozomu Kono, Yuta Shimanaka, Hiroyuki Arai, Hayashi Yamamoto, Noboru Mizushima

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 2 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 2 syntheses or guidelines pooled it, 196 citations in OpenAlex.

  1. Pooled it
  2. Stay in touch with the endoplasmic reticulum.Science China. Life sciences · 2024
    Pooled it
  3. Article
  4. Article
  5. In sample pH measurement byEuropean biophysics journal : EBJ · 2026
    Article
  6. The Human Autophagy Core Complexes.Annual review of biochemistry · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Core principles of autophagy initiation mechanisms.Nature structural & molecular biology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The therapeutic potential of (R)-carvedilol in Huntington's disease through enhancement of autophagy-lysosomal pathway via GSK-3β inhibition.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Taki NishimuraDepartment of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, The University of Tokyo, Tokyo, Japan t.nishimura@ucl.ac.uk nmizu@m.u-tokyo.ac.jp.ORCID 0000-0003-4019-5984
Norito TamuraDepartment of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Nozomu KonoDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Yuta ShimanakaDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Hiroyuki AraiDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Hayashi YamamotoDepartment of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Noboru MizushimaDepartment of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, The University of Tokyo, Tokyo, Japan t.nishimura@ucl.ac.uk nmizu@m.u-tokyo.ac.jp.ORCID 0000-0002-6258-6444
The University of Tokyo · JPUniversity of Tokyo Health Sciences · JPJapan Agency for Medical Research and Development · JPTokyo Medical and Dental University · JP

Funding

Medical Research Council MR/K015826/1
6 · The paper itself

Abstract

The autophagosome, a double-membrane structure mediating degradation of cytoplasmic materials by macroautophagy, is formed in close proximity to the endoplasmic reticulum (ER). However, how the ER membrane is involved in autophagy initiation and to which membrane structures the autophagy-initiation complex is localized have not been fully characterized. Here, we were able to biochemically analyze autophagic intermediate membranes and show that the autophagy-initiation complex containing ULK and FIP200 first associates with the ER membrane. To further characterize the ER subdomain, we screened phospholipid biosynthetic enzymes and found that the autophagy-initiation complex localizes to phosphatidylinositol synthase (PIS)-enriched ER subdomains. Then, the initiation complex translocates to the ATG9A-positive autophagosome precursors in a PI3P-dependent manner. Depletion of phosphatidylinositol (PI) by targeting bacterial PI-specific phospholipase C to the PIS domain impairs recruitment of downstream autophagy factors and autophagosome formation. These findings suggest that the autophagy-initiation complex, the PIS-enriched ER subdomain, and ATG9A vesicles together initiate autophagosome formation.

Indexed as

Organelle BiogenesisAnimalsAutophagosomesAutophagy-Related Protein-1 HomologAutophagy-Related ProteinsCDP-Diacylglycerol-Inositol 3-PhosphatidyltransferaseCell LineEndoplasmic ReticulumHumansIntracellular Signaling Peptides and ProteinsMiceProtein TransportAutophagy-Related Protein-1 HomologAutophagy-Related ProteinsCDP-Diacylglycerol-Inositol 3-PhosphatidyltransferaseIntracellular Signaling Peptides and ProteinsRb1cc1 protein, mouseUlk1 protein, mouseATG9AautophagyFIP200phosphatidylinositol synthasethe ULK complex

Identifiers

PMID28495679
PMCPMC5470044
OpenAlexW2612993240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.